Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemo-immunotherapy. Â
Plain English Summary of the Publication:
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemo-immunotherapy.
Exploring the Future of Chemotherapy with Professor Jessica Okosun Â
Professor Jessica Okosun, FLF Scientific Advisor, answers your questions on chemotherapy-free options
Patient Survey Insights – Exploring FL Patient Experiences with Immunotherapy and Communication Preferences Â
Global patient survey results reveal key insights into patient perspectives on immunotherapy and information preferences
Our Webinar Series – Register Your Interest
Our webinars are free, interactive, and designed to empower everyone affected by FL. Register today and stay informed on these important discussions.
Mid-Year Update on Follicular Lymphoma Pathways for Clinical and Translational Investigations
We are pleased to announce the publication of our latest update, “Follicular Lymphoma: Mid-year Update on Pathways for Clinical and Translational Investigations.
Blood Cancer Awareness Month – you can make a difference
Every 3 minutes, someone in the U.S. is diagnosed with blood cancer. Blood Cancer Awareness Month highlights leukemia, lymphoma, and myeloma.
Anne and Stewart’s fundraising story
Anne and Stewart recently completed an incredible 432-mile cycling journey in Scotland, raising over £2000 for the FLF.
Webinar: Understanding Follicular Lymphoma Clinical Trials
View our webinar focused on sharing experiences and improving understanding of clinical trials.
$2.25 Million to Research United to CURE Follicular Lymphoma
This strategic alliance with LLS and IFLI will further accelerate pioneering research and help cure follicular lymphoma through our Research United to CURE FL program.
Latest follicular lymphoma research updates from recent scientific conferences
The team updates from recent scientific conferences on the latest research in follicular lymphoma, from cutting-edge therapies to genetic insights.